MET and neoplasm: Activation of the HGF/c-MET signaling pathway contributes to the promotion of tumor cell motility, scattering, invasion, and metastasis, suggesting it to be a negative prognostic indicator for cell survival and recurrence in some solid tumors including lung cancer [1, 2].